Zimmer Biomet Holdings, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 1.65 B

Zimmer Biomet Holdings, Inc. Operating Cash Flow is USD 1.65 B for the Trailing 12 Months (TTM) ending March 31, 2025, a 10.14% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Zimmer Biomet Holdings, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 1.50 B, a 10.82% change year over year.
  • Zimmer Biomet Holdings, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 1.36 B, a -9.04% change year over year.
  • Zimmer Biomet Holdings, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 1.49 B, a 48.98% change year over year.
  • Zimmer Biomet Holdings, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 1.00 B, a -42.95% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities